Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Bacterial Infections and Mycoses

Free Subscription 26.01.2026 1 Am J Pathol 1 BMC Pediatr 3 Clin Infect Dis 1 Curr Microbiol 15 Diagn Microbiol Infect Dis 2 Eur J Clin Microbiol Infect Dis 2 Infect Immun 32 J Antimicrob Chemother 4 J Bacteriol 1 J Clin Microbiol 16 J Infect Dis 1 J Med Chem 1 J Med Microbiol 1 J Virol 1 MMWR Morb Mortal Wkly Rep 1 Nat Med 2 PLoS Negl Trop Dis 11 PLoS One 2 PLoS Pathog 1 Proc Natl Acad Sci U S A 2 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Pathol

1. OLSEN RJ, Long SW, Vedaraju Y, Tomasdottir S, et al
   Intrahost Genomic Variation of Haemophilus influenzae Isolates from Asymptomatic Nasopharyngeal Carriers Involves Genes Encoding Proteins with Diverse Inferred Functions.
   Am J Pathol. 2026;196:479-492.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

2. PEREIRA PLG, Rodrigues GJC, Ferraz ML, Souza MD, et al
   Spatial analysis of meningococcal c vaccination coverage in children in BRAZIL between 2012 and 2024.
   BMC Pediatr. 2025 Dec 7. doi: 10.1186/s12887-025-06305.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

3. STARKE S, Thomas K, Jasuja S, Lubelchek R, et al
   Short-Course Tuberculosis Preventive Therapy in a High Migration Setting: Early Experience With 1HP in Cook County, Illinois.
   Clin Infect Dis. 2026 Jan 21:ciaf723. doi: 10.1093.
   PubMed         Abstract available
   
   
4. SWEETSER B, Nguyen H, Dang H, Katumba D, et al
   Evaluating the Cepheid Xpert TB/LTBI research-use-only assay for detection of active and latent Mycobacterium tuberculosis infection.
   Clin Infect Dis. 2026 Jan 21:ciag005. doi: 10.1093.
   PubMed         Abstract available
   
   
5. NEOH CF, Chen SC, Morris AJ, Heath CH, et al
   Current Epidemiology and Infection Characteristics of Non-Aspergillus Mold Infections: A Multicenter Study in Australia and New Zealand.
   Clin Infect Dis. 2026 Jan 21:ciag029. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Curr Microbiol

6. NAMIKI T, Takada K, Hayakawa S, Komine-Aizawa S, et al
   Candida Tropicalis Biofilm Formation Under Secondary Bile Salt Sodium Deoxycholate.
   Curr Microbiol. 2026;83:144.
   PubMed         Abstract available
   
   

   
   Diagn Microbiol Infect Dis

7. LAMPROS M, Romeo E, Kittas C, Kafritsas G, et al
   Aspergillus fumigatus brain abscess in an immunocompromised patient receiving a second-generation Bruton Tyrosine Kinase inhibitor (BTKi).
   Diagn Microbiol Infect Dis. 2026;114:117270.
   PubMed         Abstract available
   
   
8. PADHY S, Sahoo MP, Rout AN, Paul D, et al
   Beyond soil and pets: Nannizzia gypsea causing kerion in a child.
   Diagn Microbiol Infect Dis. 2026;114:117243.
   PubMed         Abstract available
   
   
9. SELLERA FP, Furlan JPR, da Silva LCBA, Sartori L, et al
   United we stand, divided we fall: Strengthening clinical alliances between human and veterinary medicine to tackle global priority antimicrobial-resistant bacterial pathogens.
   Diagn Microbiol Infect Dis. 2026;114:117231.
   PubMed         Abstract available
   
   
10. BOUILLON M, Malandain D, Dargere S, Cattoir V, et al
    Revisiting the time to positivity in blood cultures as a prediagnostic tool: an in vitro experiment and retrospective study.
    Diagn Microbiol Infect Dis. 2026;114:117224.
    PubMed         Abstract available
    
    
11. MATEO LEON C, Rodriguez Martin S, Garcia Martinez de Artola D, Portillo A, et al
    Borrelia crocidurae meningoencephalitis in a young Senegalense man returning to Tenerife, Canary Islands.
    Diagn Microbiol Infect Dis. 2026;114:117227.
    PubMed         Abstract available
    
    
12. POEY N, Guiraud J, Balcon C, Aladjidi N, et al
    Mycoplasma pneumoniae macrolide resistance acquisition in a CCR2-deficient child.
    Diagn Microbiol Infect Dis. 2026;114:117219.
    PubMed         Abstract available
    
    
13. OZAN KOSE S, Erdem H, Kose OC, Yilmaz Erturk F, et al
    A clinical pitfall in caseating necrotizing granulomatous lymphadenitis: Tularemia.
    Diagn Microbiol Infect Dis. 2026;114:117228.
    PubMed         Abstract available
    
    
14. JEAN-CLEMENT R, Marine D, Mathilde S, Christine B, et al
    Unmasking the unexpected: Neuroinvasive listeriosis complicating influenza pneumonia.
    Diagn Microbiol Infect Dis. 2026;114:117214.
    PubMed         Abstract available
    
    
15. LECORCHE E, Billard-Pomares T, Alaoui FM, Gallois E, et al
    Impact of delayed incubation on mycobacterial blood culture recovery with the BACTEC Myco/F Lytic system.
    Diagn Microbiol Infect Dis. 2026;114:117217.
    PubMed         Abstract available
    
    
16. XU B, Zhang H, Li M, Lin H, et al
    Application of metagenomic next-generation sequencing in diagnose the pulmonary infections caused by Aureobasidium melanogenum: A case report and review of the literature.
    Diagn Microbiol Infect Dis. 2026;114:117213.
    PubMed         Abstract available
    
    
17. TANURE YCB, Geranutti MJ, Ventura SS, do Nascimento IJB, et al
    Impact of MRSA nasal swab screening and PCR in pneumonia treatment and antimicrobial stewardship: A systematic review and meta-analysis.
    Diagn Microbiol Infect Dis. 2026;114:117204.
    PubMed         Abstract available
    
    
18. LOCHER K, Torchinsky M, Belanger C, Velapatino B, et al
    Analytical performance evaluation of the biofire SPOTFIRE respiratory and sore throat panel.
    Diagn Microbiol Infect Dis. 2026;114:117207.
    PubMed         Abstract available
    
    
19. LIANG XX, Wei CW
    Clinical characteristics and outcomes of nocardiosis: A retrospective analysis of 44 cases.
    Diagn Microbiol Infect Dis. 2026;114:117205.
    PubMed         Abstract available
    
    
20. FERNANDEZ-RUIZ M, Perez-Ayala A, Castano Amores MV, Del Nogal Labrador F, et al
    False-positive results of the turbidimetric beta-D-glucan assay in patients with bacteremia.
    Diagn Microbiol Infect Dis. 2026;114:117186.
    PubMed         Abstract available
    
    
21. CHEN PK, Lin KH, Ke GM, Yang SC, et al
    The role of P30 adhesin detected by ultrasensitive ELISA in the clinical diagnosis and management of Mycoplasma pneumoniae.
    Diagn Microbiol Infect Dis. 2026;114:117192.
    PubMed         Abstract available
    
    

    
    Eur J Clin Microbiol Infect Dis

22. SUNNERHAGEN T, Mnajed R, Torngren A, Blackberg A, et al
    Bacteraemia with Streptococcus agalactiae - an observational study on clinical aspects and time to blood culture positivity.
    Eur J Clin Microbiol Infect Dis. 2026 Jan 23. doi: 10.1007/s10096-026-05411.
    PubMed        
    
    
23. CALLEBAUT K, Hellemans J, Chin T, Flore K, et al
    Prospective surveillance of Candida auris and assessment of diagnostic approaches in a Belgian hospital.
    Eur J Clin Microbiol Infect Dis. 2026 Jan 23. doi: 10.1007/s10096-026-05409.
    PubMed        
    
    

    
    Infect Immun

24. VAN MEIJGAARDEN KE, Grace PS, Freund NT, Achkar JM, et al
    Antibodies in tuberculosis: functional capacity as key determinant.
    Infect Immun. 2026 Jan 21:e0039425. doi: 10.1128/iai.00394.
    PubMed         Abstract available
    
    
25. VAN DEN BIGGELAAR RHGA, Ottenhoff THM
    mTORC1 inhibitors rapamycin and everolimus as host-directed therapy for tuberculosis.
    Infect Immun. 2026 Jan 21:e0054425. doi: 10.1128/iai.00544.
    PubMed        
    
    

    
    J Antimicrob Chemother

26. COLE MJ, Doumith M, Vickers A, Alexander S, et al
    In vitro activity of gepotidacin against a challenging panel of multidrug-resistant Neisseria gonorrhoeae isolates.
    J Antimicrob Chemother. 2026;81:dkag001.
    PubMed         Abstract available
    
    
27. NIJHUIS J, Jansen AME, Wolfs TFW, Muilwijk EW, et al
    Real-world evaluation of isavuconazole in children with cancer.
    J Antimicrob Chemother. 2026;81:dkaf485.
    PubMed         Abstract available
    
    
28. SWEENEY EL, Tickner JA, Ertl NG, Bauer MJ, et al
    Rapid molecular diagnostics for detection of extensively drug-resistant Salmonella Typhi.
    J Antimicrob Chemother. 2026;81:dkaf481.
    PubMed         Abstract available
    
    
29. CHAVANET P, Matheux A, Sixt T, Barbet J, et al
    Penetration of daptomycin in cerebrospinal fluid during pneumococcal meningitis.
    J Antimicrob Chemother. 2026;81:dkaf474.
    PubMed         Abstract available
    
    
30. ZHANG X, Xie Y, Liu F, Cheng Z, et al
    Simulated lung exposure in pneumonia patients to evaluate the antibacterial capacity and resistance suppression of clinical tigecycline regimens against carbapenem-resistant Acinetobacter baumannii.
    J Antimicrob Chemother. 2026;81:dkaf477.
    PubMed         Abstract available
    
    
31. WU M, Li J, Zhou Z, Chen Y, et al
    Research progress on resistance mechanisms and clinical efficacy of tigecycline against Klebsiella pneumoniae.
    J Antimicrob Chemother. 2026;81:dkaf504.
    PubMed         Abstract available
    
    
32. STURM PDJ, Van Niekerk JM, Lestrade PPA, Peters CJA, et al
    Prevalence of macrolide resistance in Mycoplasma pneumoniae in The Netherlands.
    J Antimicrob Chemother. 2026;81:dkaf475.
    PubMed         Abstract available
    
    
33. DWIBEDY SK, Padhy I, Mohapatra SS
    A comprehensive analysis of the mutational landscape determining polymyxin resistance in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2026;81:dkaf503.
    PubMed         Abstract available
    
    
34. ZHUO J, Xu J, Chi Y, Zhang N, et al
    Ceftazidime/avibactam: a potent arsenal against multidrug-resistant Pseudomonas aeruginosa-unveiling in vitro and in vivo strategies.
    J Antimicrob Chemother. 2026;81:dkaf495.
    PubMed         Abstract available
    
    
35. MIELKO-NIZIALEK KA, Jablonski S, Wisniewski J, Milczewska J, et al
    Antibiotic resistance of Pseudomonas aeruginosa strains-intracellular metabolomics analysis.
    J Antimicrob Chemother. 2026;81:dkaf453.
    PubMed         Abstract available
    
    
36. MAERTENS J, Birne R, Felton T, Neofytos D, et al
    Liposomal amphotericin B and renal safety: review of the evidence and clinical considerations.
    J Antimicrob Chemother. 2026;81:dkaf473.
    PubMed         Abstract available
    
    
37. SAAD BAA, Volpe-Chaves CE, de Oliveira CTF, Conte BS, et al
    The emerging clinical relevance and antimicrobial resistance of Pluralibacter gergoviae: a systematic review.
    J Antimicrob Chemother. 2026;81:dkaf476.
    PubMed         Abstract available
    
    
38. WANG X, Yin X, Liu Y, Jin Y, et al
    Comparison of disk diffusion, MIC test strip and broth microdilution for eravacycline susceptibility testing of 422 Staphylococcus aureus isolates using ChinaCAST breakpoints.
    J Antimicrob Chemother. 2026;81:dkaf502.
    PubMed         Abstract available
    
    
39. TASCINI C, Bianco G, Bonomo RA, Gaibani P, et al
    In vitro activity of cefepime/zidebactam against sulbactam/durlobactam-susceptible and -resistant Acinetobacter baumannii clinical isolates.
    J Antimicrob Chemother. 2026;81:dkaf467.
    PubMed         Abstract available
    
    
40. MCCRACKEN M, Lerminiaux N, Adam HJ, Baxter M, et al
    Enterococcus faecium harbouring vanA, optrA and cfr(D) on a linear plasmid in Canada: a CANWARD surveillance case.
    J Antimicrob Chemother. 2026;81:dkaf478.
    PubMed         Abstract available
    
    
41. WANG X, Zhang H, Song S, Tang X, et al
    Impact of extracorporeal membrane oxygenation modes on voriconazole exposure in critically ill patients.
    J Antimicrob Chemother. 2026;81:dkaf501.
    PubMed         Abstract available
    
    
42. NUCCI M, Maertens J
    Redefining antifungal prophylaxis in acute leukaemia in the era of targeted therapies.
    J Antimicrob Chemother. 2026;81:dkag010.
    PubMed         Abstract available
    
    
43. MACPHAIL A, Attwood LO, Rogers BA
    Long-acting glycopeptides: what are the barriers to access in patients who need them most, and how can they be overcome?
    J Antimicrob Chemother. 2026;81:dkaf471.
    PubMed         Abstract available
    
    
44. NIELSEN MBD, Mikkelsen MKD, Rasmussen HC, Hvistendahl MA, et al
    Cefepime/enmetazobactam for Gram-negative periprosthetic joint infections? A randomized porcine study on target tissue pharmacokinetics.
    J Antimicrob Chemother. 2026;81:dkaf487.
    PubMed         Abstract available
    
    
45. ZHAO R, Wan P, Huang H, Li Q, et al
    Harnessing CRISPR-Cas9 and CRISPRi systems to reverse antibiotic resistance in a clinical multidrug-resistant Escherichia coli isolate.
    J Antimicrob Chemother. 2025 Dec 24:dkaf442. doi: 10.1093.
    PubMed         Abstract available
    
    
46. DUTKIEWICZ M, Jousset AB, de Swardt H, Rezzoug I, et al
    In vitro susceptibility of cefepime-enmetazobactam, cefepime-taniborbactam and cefepime-zidebactam towards carbapenemase-producing Enterobacterales.
    J Antimicrob Chemother. 2026;81:dkaf440.
    PubMed         Abstract available
    
    
47. KUIL S, Bavalia R, Boyd A, de Jong M, et al
    Local antibiotic resistance surveillance in nursing homes using lot quality assurance sampling: a feasibility study.
    J Antimicrob Chemother. 2025 Dec 17:dkaf451. doi: 10.1093.
    PubMed         Abstract available
    
    
48. SHAW D, Thakur S, Ghosh A, Dogra S, et al
    Efflux-mediated multidrug resistance mechanism in Trichophyton indotineae and Trichophyton rubrum; role of ABC transporters and MFS gene.
    J Antimicrob Chemother. 2026;81:dkaf434.
    PubMed         Abstract available
    
    
49. MOSTAFA R, Mohammed S, Ahmed AS, Aly SA, et al
    Nanoparticle-based co-delivery of ciprofloxacin and meropenem enhances synergistic activity against multidrug-resistant hypervirulent Klebsiella pneumoniae clinical isolates.
    J Antimicrob Chemother. 2026;81:dkaf422.
    PubMed         Abstract available
    
    
50. TANG B, Hu X, Song Y, Liu X, et al
    Acquired antimicrobial resistance genes in Bordetella Species: a global genomic analysis.
    J Antimicrob Chemother. 2025 Dec 1:dkaf418. doi: 10.1093.
    PubMed         Abstract available
    
    
51. HAUSBERGER CF, Peng L, Balasubramani GK, Shields RK, et al
    Epidemiology and treatment of endocarditis secondary to Enterobacterales other than Serratia spp.
    J Antimicrob Chemother. 2026;81:dkaf432.
    PubMed         Abstract available
    
    
52. MIN P, Yao J, Ruan S, Zhou L, et al
    Global phylogeography and genomic characterization of blaNDM-1-positive carbapenem-resistant Acinetobacter soli.
    J Antimicrob Chemother. 2025 Nov 24:dkaf437. doi: 10.1093.
    PubMed         Abstract available
    
    
53. VERMA S, Tilak R, Singh G, Singh S, et al
    Multicentre investigation of Wickerhamomyces anomalus fungemia in India: emerging resistance and mechanistic insights.
    J Antimicrob Chemother. 2026;81:dkaf420.
    PubMed         Abstract available
    
    
54. GOH M, Eisenkraft Klein D, Kesselheim AS
    The curious constraints on clofazimine.
    J Antimicrob Chemother. 2026;81:dkaf430.
    PubMed         Abstract available
    
    
55. ANDERSSON M, Zimmermann N, Kloft C, Aulin LBS, et al
    Antibiotic pharmacodynamics: from MIC to advanced metrics and their applications.
    J Antimicrob Chemother. 2026;81:dkaf374.
    PubMed         Abstract available
    
    
56. BETTUZZI T, Strady C, Diamantis S, Matta M, et al
    Differences in prescription for impetigo and cellulitis across years in three European countries.
    J Antimicrob Chemother. 2026;81:dkaf400.
    PubMed         Abstract available
    
    
57. ZHU Z, Hua X, Ke Y
    Azithromycin resistance in non-typhoidal Salmonella: a review.
    J Antimicrob Chemother. 2026;81:dkaf341.
    PubMed         Abstract available
    
    

    
    J Bacteriol

58. HRITZO BA, Michalski JM, Rasko DA
    Characterization of the role of putative Aeromonas caviae-specific virulence factor, flgB, in virulence and host-pathogen interactions.
    J Bacteriol. 2026;208:e0033925.
    PubMed         Abstract available
    
    
59. APPELL KT, Guo W, Scott M, Blevins JS, et al
    Yersinia pestis plasminogen activator protease is regulated by the PhoP/PhoQ two-component system.
    J Bacteriol. 2026;208:e0035725.
    PubMed         Abstract available
    
    
60. WANG X, Yao P, Liu L, Zhang Y, et al
    Functional divergence and regulatory network of the type VI secretion system in Vibrio parahaemolyticus.
    J Bacteriol. 2026;208:e0037825.
    PubMed         Abstract available
    
    
61. TRAN VN, Burrows LL
    Steering the course: targeting and exploiting surface receptors in phage therapy.
    J Bacteriol. 2026;208:e0037525.
    PubMed         Abstract available
    
    

    
    J Clin Microbiol

62. TIAN Y, He X, Wu X, Liu Y, et al
    Performance of gradient diffusion strip and disk diffusion versus broth microdilution for lefamulin susceptibility testing of 422 Staphylococcus aureus isolates.
    J Clin Microbiol. 2026 Jan 23:e0157825. doi: 10.1128/jcm.01578.
    PubMed         Abstract available
    
    

    
    J Infect Dis

63. JI J, Jiang X, Liao X, Du F, et al
    A monovalent SMAC mimetic as a potential host-directed therapy for tuberculosis.
    J Infect Dis. 2026 Jan 20:jiag031. doi: 10.1093.
    PubMed         Abstract available
    
    
64. MITRA SD, Soneji M, Axline CMR, Hayden HS, et al
    Culture and Adaptation of Pseudomonas aeruginosa During Early Infection in Children With Cystic Fibrosis.
    J Infect Dis. 2026;233:e67-e76.
    PubMed         Abstract available
    
    
65. CRUMP JA, Mogeni P, Ajanovic SA, Bramugy JM, et al
    Leptospirosis Prevalence and Risk Factors Among Patients Presenting With Fever to 4 Healthcare Sites in Sub-Saharan Africa and South East Asia: An International Multisite Observational and Nested Case-Control Study.
    J Infect Dis. 2026;233:e259-e270.
    PubMed         Abstract available
    
    
66. ZHANG G, Shen Q, Ye J, Feng Y, et al
    Single-Cell Transcriptome Profiling Reveals the Immune Dysregulation Characteristics of Mice Infected With Brucella abortus.
    J Infect Dis. 2026;233:e55-e66.
    PubMed         Abstract available
    
    
67. BISHOP K, Moosa F, Makhasi M, Kleynhans J, et al
    Comparing Respiratory Illness Surveillance Case Definitions to Detect Bordetella pertussis in Children Aged <5 Years With Respiratory Illness in South Africa, 2017-2023.
    J Infect Dis. 2026;233:e34-e43.
    PubMed         Abstract available
    
    
68. MOORTHY GS, Blocher BH, Madut DB, Miller HK, et al
    Antibodies to Tick Salivary Antigens AV422 and Calreticulin in Patients With Spotted Fever Group Rickettsioses and Other Febrile Illnesses in Northern Tanzania.
    J Infect Dis. 2026;233:206-215.
    PubMed         Abstract available
    
    
69. EVANS D, Friedman B, Pung K, Weber B, et al
    Insights on Recurrent and Sequential Clostridioides difficile Infections From Genomic Surveillance in Minnesota, USA, 2019-2021.
    J Infect Dis. 2026;233:e44-e54.
    PubMed         Abstract available
    
    
70. SRIDHAR S, Worby CJ, Bronson RA, Turbett SE, et al
    Insights Into Global Antimicrobial Resistance Dynamics Through the Sequencing of Enteric Bacteria From US International Travelers.
    J Infect Dis. 2025 Sep 24:jiaf469. doi: 10.1093.
    PubMed         Abstract available
    
    
71. JUNG S, Dahesh S, Bjanes E, Monk J, et al
    Investigating Azithromycin Activity Against ESBL-Producing Escherichia coli Under Physiologically Relevant Conditions.
    J Infect Dis. 2026;233:70-75.
    PubMed         Abstract available
    
    
72. LETHBRIDGE J, Freppel W, Ho MF, Skinner EB, et al
    Seroprevalence of Antibodies Against Legionella Species in Northeastern Australian Blood Donors, 2016 and 2023.
    J Infect Dis. 2026;233:e239-e249.
    PubMed         Abstract available
    
    
73. MADUT DB, Rubach MP, Scheutz F, Call DR, et al
    Population Structure of Escherichia coli Isolated From the Human Bloodstream, Human and Animal Feces, and the Environment in Northern Tanzania.
    J Infect Dis. 2026;233:112-121.
    PubMed         Abstract available
    
    
74. XU W, Antonello J, Nguyen J, Ma C, et al
    Low intrinsic killing activity and no impact of its positivity on phase 3 pneumococcal vaccine adult studies.
    J Infect Dis. 2025 Aug 11:jiaf427. doi: 10.1093.
    PubMed         Abstract available
    
    
75. FELTON EA, Jobson ME, Torres NJ, Washburn RM, et al
    Emergence of ST3390: A Novel Apigmented MRSA Clone From the CC5 Lineage.
    J Infect Dis. 2026;233:27-37.
    PubMed         Abstract available
    
    
76. MCCLUSKEY JM, Wichman CS, Degarege A, Brett-Major D, et al
    Leveraging Lyme Disease Surveillance to Simulate Powassan Virus Prevalence.
    J Infect Dis. 2026;233:148-152.
    PubMed         Abstract available
    
    
77. YOU SS, Shrestha M, Bourgeois JS, Clendenen LH, et al
    Hygromycin A Treatment of Borrelia burgdorferi-Infected Peromyscus leucopus Suggests Potential as a Reservoir-Targeted Antibiotic.
    J Infect Dis. 2026;233:96-100.
    PubMed         Abstract available
    
    
78. CHO E, Kim J, Won T, Ryu S, et al
    Virulent Bacteriophages for Controlling Shiga Toxin-Producing Escherichia coli Without Inducing Toxin Production.
    J Infect Dis. 2026;233:87-95.
    PubMed         Abstract available
    
    

    
    J Med Chem

79. WEN R, Xing G, Li H, Yang J, et al
    Design, Synthesis, and Biological Evaluation of Acid-Responsive Bifunctional Molecules with Dual Anti-Helicobacter pylori and Acid Suppression Activities.
    J Med Chem. 2026;69:1342-1357.
    PubMed         Abstract available
    
    

    
    J Med Microbiol

80. MAYORGA M, Wheatley JL, Maldonado BN, Chavez-Bueno S, et al
    Bovine lactoferrin maintains antibacterial effect against neonatal Escherichia coli septicaemia isolates despite the presence of iron acquisition genes.
    J Med Microbiol. 2026;75:002116.
    PubMed         Abstract available
    
    

    
    J Virol

81. FENG C, Cheng Y, Liang S, Liang R, et al
    Identification and analysis of the crucial holin domain and sites and the bactericidal activity of a holin-endolysin lysis cassette from phage PZL-Ah152 against Aeromonas hydrophila.
    J Virol. 2026;100:e0083225.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

82. VERA-GARCIA C, Duran-Pena O, Ramirez M, Vonnahme L, et al
    Continuity of Care for Patients with Tuberculosis Relocating to Other Countries - CureTB Program, 2016-2023.
    MMWR Morb Mortal Wkly Rep. 2026;75:34-40.
    PubMed         Abstract available
    
    

    
    Nat Med

83. BRYANT JA, Vulic M, Walsh EA, Allen EG Jr, et al
    The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome.
    Nat Med. 2026;32:186-196.
    PubMed         Abstract available
    
    

    
    PLoS Negl Trop Dis

84. LONG Y, Tian J, Han P, Wu S, et al
    Molecular detection of Orientia tsutsugamushi infection in bats from the China-Myanmar border.
    PLoS Negl Trop Dis. 2026;20:e0013860.
    PubMed         Abstract available
    
    
85. GYAMFI E, Dogbe M, Sarpong-Duah M, Kyei-Baffour ES, et al
    Comparative analysis of Buruli ulcer in Ghana and Cote d'Ivoire: A cross-sectional study.
    PLoS Negl Trop Dis. 2026;20:e0013912.
    PubMed         Abstract available
    
    

    
    PLoS One

86. SULIS G, Maredia N, Wolfson C, Basta NE, et al
    Changes in pneumococcal vaccine coverage in the Canadian Longitudinal Study on Aging (CLSA): An analysis based on the 2018-2021 follow-up 2 survey.
    PLoS One. 2026;21:e0338213.
    PubMed         Abstract available
    
    
87. ABERA D, Mihret A, Fentaw S, Beyene E, et al
    Extended-spectrum beta-lactamase and carbapenemase-producing Enterobacterales among adult patients and their family members at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
    PLoS One. 2026;21:e0341636.
    PubMed         Abstract available
    
    
88. ALAHMAR AJ, Elhosseiny NM, Mahmoud RR, Attia AS, et al
    Transcriptional regulator NtrC modulates nitrogen assimilation, virulence, and the extracellular glutamine synthetase activity in Acinetobacter baumannii.
    PLoS One. 2026;21:e0341569.
    PubMed         Abstract available
    
    
89. KANEKI M, Ohira C, Takahashi M, Fukuyama T, et al
    Preventive effect of bentonite against pyoderma via direct binding capability of staphylococci.
    PLoS One. 2026;21:e0341148.
    PubMed         Abstract available
    
    
90. MILISAVLJEVIC J, Stosic M, Jovanovic N, Adzic Vukicevic T, et al
    Latent TB infection in solid organ transplant recipients in Serbia: A single center experience from a low TB burden country.
    PLoS One. 2026;21:e0339925.
    PubMed         Abstract available
    
    
91. KIBRIA AM, Islam MN, Alam MS, Adhikari BJ, et al
    Estimated true prevalence and associated risk factors of bovine paratuberculosis antibodies in dairy herds in Bangladesh.
    PLoS One. 2026;21:e0334683.
    PubMed         Abstract available
    
    
92. YE L, Yu G, Cheng Y, Fan L, et al
    DnaK supports intracellular persistence of Staphylococcus xylosus and confers mechanical resilience to a human breast cancer cell line.
    PLoS One. 2026;21:e0341069.
    PubMed         Abstract available
    
    
93. QING C, Sun W, Yang C, Yao Y, et al
    Cell death-related gene signatures as dual-function biomarkers: Early diagnosis and therapeutic targeting in Staphylococcus aureus pneumonia.
    PLoS One. 2026;21:e0339560.
    PubMed         Abstract available
    
    
94. YANG Z, Choi I, Yun H, Kim S, et al
    Deep learning detection and classification of fungal and non-fungal calcifications on paranasal sinus CT imaging.
    PLoS One. 2026;21:e0340832.
    PubMed         Abstract available
    
    
95. HAILEMICHAEL EB, Desta AF, Taye G, Gari SR, et al
    Prevalence, microbiological profiles, and determinants of hospital-acquired pneumonia in Addis Ababa: A focus on Pseudomonas aeruginosa and its antimicrobial resistance patterns in three hospitals.
    PLoS One. 2026;21:e0340680.
    PubMed         Abstract available
    
    
96. ALVENDAL C, Hasselrot T, Balduck M, Edfeldt G, et al
    Vaginal chlorhexidine gluconate versus fluconazole for recurrent vulvovaginal candidiasis: A randomized noninferiority trial.
    PLoS One. 2026;21:e0340862.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

97. AHMAD SS, Ebohon O, McClune ME, Trimble RN, et al
    Peptidoglycan architecture dictates protein interactions, tissue tropism, and arthritis in the Lyme disease spirochete Borrelia burgdorferi.
    PLoS Pathog. 2026;22:e1013849.
    PubMed         Abstract available
    
    
98. TAHIRI G, Lax C, Binder U, Scheler J, et al
    A BRCT domain-containing protein induced in early phagocytosis plays a crucial role in the pathogenesis of the mucoralean Rhizopus microsporus.
    PLoS Pathog. 2026;22:e1013653.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

99. KATHARIOS-LANWERMEYER S, Zarrella TM, Godsil M, Severin S, et al
    A quorum-sensing molecule from Pseudomonas aeruginosa induces defensive multicellularity in a coinfecting pathogen.
    Proc Natl Acad Sci U S A. 2026;123:e2513122123.
    PubMed         Abstract available
    
    

    
    Science

100. ZUCKERMAN MK, Bailey L
     Uncovering the secrets of syphilis.
     Science. 2026;391:352-353.
     PubMed         Abstract available
     
     
101. BOZZI D, Broomandkhoshbacht NZ, Delgado M, Buikstra JE, et al
     A 5500-year-old Treponema pallidum genome from Sabana de Bogota, Colombia.
     Science. 2026;391:eadw3020.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge.